Autoinflammatory & rare systemic diseases
Evaluation and Management of Deficiency of Adenosine Deaminase 2: An International Consensus Statement
Methodological detailsmodified Delphi process, comprehensive literature review, Oxford Center for Evidence-Based Medicine Levels of Evidence
- Modified Delphi process
- Comprehensive literature review
- Oxford Center for Evidence-Based Medicine Levels of Evidence
Recommendations
As issued by the authors
Consensus statements for diagnostic testing
Consensus statements for screening
Consensus statements for clinical and laboratory evaluation
Consensus statements for management of DADA2 based on disease phenotype
Consensus statements for evaluation and treatment of presymptomatic individuals with DADA2 and carriers
Original publication
Evaluation and Management of Deficiency of Adenosine Deaminase 2: An International Consensus Statement. JAMA Netw Open. Published 1 May 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →